Anaplastic astrocytoma | Primary Research (KOL's Insight) | Market Intelligence | Epidemiology & Market Forecast-2035

A particular kind of brain tumor is anaplastic astrocytoma. The brain's astrocytes, which are a type of tissue that safeguards nerve cells in the brain and spinal cord, are where they develop. By their characteristics, astrocytomas are categorized. Men are a little more likely than women to develop anaplastic astrocytoma. It is unknown how frequently these tumors occur. On average, 5-8 individuals with anaplastic astrocytomas and glioblastomas are thought to be affected annually per 100,000 people. Surgery to remove the tumor or as much of the tumor as is possible is typically the first line of treatment for anaplastic astrocytoma. Special care must be taken during surgery to monitor and protect these functions because anaplastic astrocytomas can develop in or close to regions of the brain that regulate bodily functions like movement, sensation, language, and vision.

Description

Anaplastic Astrocytoma is a type of brain tumor. They grow in astrocytes, star-shaped brain cells that are a component of the tissue that covers nerve cells in the brain and spinal cord. According to their makeup, astrocytes are categorized. Astrocytomas in grades 1 and 2 are benign, or slow-growing, and do not spread to other parts of the body. Astrocytomas in grades 3 and 4 are more aggressive and malignant, or precancerous lesions. Grade III astrocytomas include anaplastic astrocytomas. Despite being uncommon, if untreated, it can still be very dangerous. The majority of anaplastic astrocytomas are sporadic, with no known cause. The presence of signs and symptoms such as headache, lethargy, vomiting, and changes in personality or mental state can vary depending on the location and size of the tumor. Some affected people experience seizures, vision issues, limb weakness, and/or issues with coordination. Anaplastic astrocytomas are uncommon but can be linked to some rare genetic disorders.

Anaplastic astrocytoma (Epidemiology)

Men are slightly more affected than women by anaplastic astrocytoma. Unknown is the frequency of these tumors. Out of every 100,000 people in the population, 5-8 are thought to be affected annually by anaplastic astrocytomas and glioblastomas. Adults are more likely than children to develop anaplastic astrocytoma. Between the ages of 30 and 50 is when adult anaplastic astrocytomas typically manifest. The most prevalent primary brain tumors in adults are oligodendrogliomas and astrocytomas, which are related tumors. Children's anaplastic astrocytomas typically develop between the ages of 5 and 9 years. Astrocytomas that are malignant (i.e., anaplastic astrocytoma, and glioblastoma multiforme) account for approximately. 10% of pediatric CNS tumors. More than half of all primary tumors of the central nervous system in children are astrocytomas. Around 80% of pediatric astrocytomas are low-grade.

Anaplastic astrocytoma -Current Market Size & Forecast Trends

The market for anaplastic astrocytoma is projected to grow steadily, with estimates indicating a value of approximately USD 8.25 billion by 2030, reflecting a compound annual growth rate (CAGR) of 4.90% during the forecast period from 2024 to 2030. Market growth is driven by advancements in screening methods, minimally invasive treatments, and the adoption of combination therapies to address high-grade lesions effectively. Overall, the anaplastic astrocytoma market is well-positioned for gradual growth through 2035 as new treatment strategies and innovations continue to emerge.

In most cases, the first-line treatment for anaplastic astrocytoma is surgery to remove the tumor or remove as much of the tumor as possible. Because anaplastic astrocytoma can occur in or near parts of the brain that control body functions such as movement, sensation, speech, and vision, special precautions must be taken during surgery to monitor and protect these functions. Anaplastic astrocytoma spreads to adjacent healthy tissue. This means that it is difficult to completely remove all cancer cells. Therefore, surgery is usually a combination of radiotherapy and chemotherapy, chemotherapy, and radiotherapy. Sometimes surgery is not possible if the tumor is in an area that could interfere with important functions, such as in large blood vessels or near the brain stem. The specific treatment plan depends on several factors, including the tumor's location, spread to other sites, the patient's age, and general health.

Report Highlights

Anaplastic astrocytoma - Current Market Trends

Anaplastic astrocytoma - Current & Forecasted Cases across the G8 Countries

Anaplastic astrocytoma - Market Opportunities and Sales Potential for Agents

Anaplastic astrocytoma - Patient-based Market Forecast to 2035

Anaplastic astrocytoma - Untapped Business Opportunities

Anaplastic astrocytoma - Product Positioning Vis-a-vis Competitors' Products

Anaplastic astrocytoma - KOLs Insight